Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2/3 1

Status

Unknown 1Active not recruiting 1

Sponsor Class

OTHER 72OTHER_GOV 2UNKNOWN 1NETWORK 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Weight Loss 1Lung Neoplasms 1Esophageal Neoplasms 1

Interventions

Cisplatin 50Capecitabine 42apatinib 34Radiotherapy 33Oxaliplatin 33Gemcitabine 33Cyclophosphamide 32Drug Therapy 31Paclitaxel 30Carboplatin 29tislelizumab 27Irinotecan 27Fluorouracil 26Docetaxel 26Bevacizumab 23Surgical Procedures, Operative 21Nivolumab 19pembrolizumab 18fludarabine 18Radiation 16Metformin 16Exercise 16camrelizumab 15S 1 (combination) 14Control Groups 14Blood Specimen Collection 14Pemetrexed 13Standard of Care 12anlotinib 11Neoadjuvant Therapy 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER_GOV × Nutrition Assessment × Clear all
NCT03161535 2025-07-28

Effectiveness of a Rehabilitation Program in Improving Quality of Life in Patients With Esophageal Cancer

Taipei Veterans General Hospital, Taiwan

Phase NA Active not recruiting
85 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT01048970 2010-01-14

Effect on the Nutritional and Inflammatory Status of Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA)- Containing Supplement in Patients With Advanced Lung Cancer

National Institute of Cancerología

Phase 2/3 Unknown
120 enrolled
Thoracic

Lung Neoplasms, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon ⚡